Advancing our knowledge of macrophage biology in psoriasis, particularly the role of biomarkers like CD163, may unveil new therapeutic targets and pathways for personalized treatment and improved patient care, potentially leading to more effective treatments for immune cell dysregulation by addressing the innate immune mechanisms and their role in chronic inflammation, thereby improving the quality of life for those with this chronic skin condition. Here, CD163 is linked to psoriasis.